Table 1 Baseline characteristics of Danish children and adolescents with and without damaging MC4R mutations enrolled into obesity treatment.
Children with damaging or unresolved MC4R mutations (group A) | Children with benign or no MC4R mutations (group B) | p for difference between groups A and Ba | ||||
---|---|---|---|---|---|---|
n | Mean (SD) or % | n | Mean (SD) or % | Adjusted for BMI | ||
Sex, % boys | 30 | 46.7 | 1179 | 44.3 | 0.78 | 0.92 |
Age, years | 30 | 10.28 (3.68) | 1179 | 11.62 (3.08) | 0.019 | 0.022 |
BMI SDS | 30 | 3.08 (0.71) | 1179 | 2.98 (0.69) | 0.80 | – |
Height-for-age SDS | 30 | 1.18 (1.10) | 1179 | 0.92 (0.98) | 0.41 | 0.43 |
FFMI, kg/m2 (log) | 21 | 2.70 (0.16) | 865 | 2.72 (0.14) | 0.25 | 0.16 |
BFMI, kg/m2 (log) | 21 | 2.32 (0.26) | 865 | 2.41 (0.28) | 0.80 | 0.46 |
BMD, g/cm2 (log) | 21 | −0.065 (0.15) | 865 | −0.023 (0.15) | 0.58 | 0.59 |
SBP SDS | 28 | 0.73 (0.98) | 1091 | 0.70 (1.00) | 0.94 | 0.97 |
DBP SDS | 28 | −0.027 (0.97) | 1091 | 0.21 (0.78) | 0.063 | 0.057 |
Glucose, mmol/l | 21 | 5.29 (0.40) | 991 | 5.19 (0.57) | 0.24 | 0.24 |
HbA1c, mmol/mol | 23 | 35.04 (4.62) | 1032 | 34.80 (3.62) | 0.70 | 0.71 |
Insulin, pmol/l (log) | 23 | 4.67 (0.47) | 1041 | 4.76 (0.63) | 0.97 | 0.97 |
TSH, mU/l (log) | 23 | 1.30 (0.72) | 1039 | 0.98 (0.50) | 0.004 | 0.004 |
T3, nmol/l | 23 | 2.36 (0.41) | 1035 | 2.41 (0.39) | 0.44 | 0.44 |
T4, pmol/lb | 23 | 14.55 (2.54) | 1036 | 15.29 (2.05) | 0.023 | 0.022 |
Total cholesterol, mmol/lb | 23 | 4.49 (0.78) | 1028 | 4.22 (0.77) | 0.13 | 0.13 |
HDL cholesterol, mmol/l | 23 | 1.24 (0.25) | 1029 | 1.22 (0.29) | 0.98 | 0.99 |
LDL cholesterol, mmol/lb | 23 | 2.70 (0.81) | 1026 | 2.51 (0.67) | 0.22 | 0.22 |
Triglycerides, mmol/l (log) | 23 | 0.074 (0.46) | 1028 | −0.037 (0.51) | 0.18 | 0.18 |